J&J Intensifies Search For Drugs With A New Development Center In Mumbai
This article was originally published in The Pink Sheet Daily
Executive Summary
The new facility is an important milestone for the company, and it will support 80 percent of J&J's global late-phase drugs execution, global development exec says.
You may also be interested in...
J&J Expands R&D Force In Asia With Opening Of Shanghai R&D Center
SHANGHAI - Johnson & Johnson opened its Asia Pharmaceutical Research and Development Center in Shanghai April 16
J&J Teams With Advinus For Drug Discovery In India
NEW DELHI - India's Tata Group company Advinus has formed a drug discovery and early clinical development tie-up with Ortho-McNeil-Janssen Pharmaceuticals, an arm of U.S.-based Johnson & Johnson
Indian Investors Turn Cautious On Compliance Concerns
A rising number of enforcement actions by major drug regulators like the U.S. FDA is slowly making investors cautious about the longer term repercussions on earnings of Indian drug makers.